Viatris is a different kind of healthcare company founded amid the COVID-19 pandemic and with an ambitious mission: to empower people to live healthier, regardless of geography or circumstance. We do this via Access, Leadership and Partnership.
Formed in 2020 following the combination of two global pharmaceutical companies, Viatris has long and strong roots in the UK, where we have had a presence for more than six decades.
We are proud of our highly motivated and talented team of approximately 500 colleagues who work across three locations; our corporate office in Hertfordshire which is home to local, regional, and global business functions and our two sites in Cambridge and Kent, where we carry out crucial research and development for both medicines and medical devices. Collectively, everyone works to provide access to medicines, develop innovative solutions and improve healthcare for patients.
The second largest pharmaceutical supplier in the country*, and the leading company in the UK retail sector**, we have an extensive portfolio of nearly 250 products across a broad range of therapeutic areas that delivers significant value to the NHS and for UK patients.
Our medicines cover every stage of life and treat more than 5 million patients annually.1
*IQVIA MIDAS March 2021, in value and volume
**IQVIA MIDAS March 2021, in value
- Internal data on file (ex-factory sales and number of packs sold 2021 to 2022)
NON-2022-10756 November 2022